Marie Montus

Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors

Sylvie Boutin, Virginie Monteilhet, P. Véron et al. · Human Gene Therapy · 2010 · 922 citations

Vaccination, Molecular Virology, Allergy +12

Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy

Caroline Le Guiner, Laurent Servais, Marie Montus et al. · Nature Communications · 2017 · 230 citations · Full text

AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis

Anna Buj‐Bello, Françoise Fougerousse, Yannick Schwab et al. · Human Molecular Genetics · 2008 · 126 citations · Full text

Xlmtm Mouse Model, Engineering, Muscle Function +18

Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients

Caroline Le Guiner, Marie Montus, Laurent Servais et al. · Molecular Therapy · 2014 · 114 citations · Full text

Distinctive Serum miRNA Profile in Mouse Models of Striated Muscular Pathologies

Nicolas Vignier, Fatima Amor, Paul Fogel et al. · PLoS ONE · 2013 · 100 citations · Full text

Muscle Function, Engineering, Pathology +19